Decreased/VBN
concentration/NN
of/IN
1,25-dihydroxyvitamin/NN
D3/NN
receptors/NNS
in/IN
peripheral/JJ
mononuclear/JJ
cells/NNS
of/IN
patients/NNS
with/IN
X-linked/JJ
hypophosphatemic/JJ
rickets/NN
:/:
effect/NN
of/IN
phosphate/NN
supplementation/NN
./.

Abnormal/JJ
renal/JJ
tubular/JJ
phosphate/NN
transport/NN
is/VBZ
considered/VBN
to/TO
be/VB
the/DT
primary/JJ
defect/NN
in/IN
X-linked/JJ
hypophosphatemic/JJ
rickets/NN
(/(
XLH/NN
)/)
./.
=====
However/RB
,/,
the/DT
resistance/NN
to/TO
vitamin/NN
D/NN
treatment/NN
in/IN
XLH/NN
can/MD
not/RB
be/VB
explained/VBN
by/IN
hypophosphatemia/NN
alone/RB
./.
=====
Since/IN
most/JJS
of/IN
the/DT
actions/NNS
of/IN
vitamin/NN
D/NN
are/VBP
mediated/VBN
by/IN
its/PRP$
receptors/NNS
(/(
VDR/NN
)/)
,/,
abnormalities/NNS
of/IN
VDR/NN
have/VBP
been/VBN
postulated/VBN
in/IN
XLH/NN
./.
=====
In/IN
order/NN
to/TO
investigate/VB
this/DT
possibility/NN
,/,
we/PRP
measured/VBD
the/DT
concentration/NN
of/IN
VDR/NN
in/IN
PHA-activated/JJ
peripheral/JJ
mononuclear/JJ
cells/NNS
from/IN
10/CD
XLH/NN
patients/NNS
./.
=====
Patients/NNS
without/IN
phosphate/NN
supplementation/NN
showed/VBD
significantly/RB
lower/JJR
concentration/NN
(/(
21.7/CD
+/-/CC
5.1/CD
fmol/mg/NN
protein/NN
,/,
mean/NN
+/-/CC
SEM/NN
)/)
compared/VBN
to/TO
the/DT
normal/JJ
controls/NNS
(/(
60.7/CD
+/-/CC
4.0/CD
)/)
./.
=====
On/IN
the/DT
contrary/JJ
,/,
there/EX
was/VBD
no/DT
significant/JJ
difference/NN
between/IN
the/DT
phosphate-supplemented/JJ
patients/NNS
(/(
58.3/CD
+/-/CC
2.7/CD
)/)
and/CC
controls/NNS
./.
=====
There/EX
was/VBD
a/DT
significant/JJ
positive/JJ
correlation/NN
between/IN
VDR/NN
concentration/NN
and/CC
serum/NN
phosphate/NN
(/(
P/NN
less/JJR
than/IN
0.05/CD
)/)
./.
=====
In/IN
two/CD
patients/NNS
,/,
VDR/NN
was/VBD
increased/VBN
after/IN
daily/JJ
phosphate/NN
supplementation/NN
was/VBD
started/VBN
./.
=====
These/DT
results/NNS
indicate/VBP
that/IN
a/DT
decreased/VBN
concentration/NN
of/IN
VDR/NN
secondary/JJ
to/TO
persistent/JJ
hypophosphatemia/NN
is/VBZ
one/CD
of/IN
the/DT
causes/NNS
of/IN
vitamin/NN
D/NN
resistance/NN
in/IN
XLH/NN
./.